货号:GS40736
Toripalimab is a humanized monoclonal antibody targeting programmed cell death protein 1 (PD-1). It binds to PD-1 on T cells, blocking interaction with PD-L1/PD-L2 ligands to restore anti-tumor immunity. Approved in China, it is used for various cancers including melanoma, nasopharyngeal carcinoma, urothelial carcinoma, and esophageal cancer, both as monotherapy and in combination.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物